<DOC>
	<DOCNO>NCT02549365</DOCNO>
	<brief_summary>The UK Departments Health recommend annual influenza vaccination child 2-7 year age , child 7 year eligible vaccination certain high risk clinical category . Though data available document safety immunogenicity LAIV age group , little data ass efficacy immune correlate UK child , particular atopic child . This study enrol 200 child ( least 200 unvaccinated household sibling control ) , many history asthma recurrent wheezing , allow assessment efficacy , safety immune correlate child , varies prior administration pandemic influenza vaccine and/or LAIV .</brief_summary>
	<brief_title>Efficacy &amp; Safety Nasal Influenza Immunisation Children</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 2 18 year old Written inform consent parent/guardian ( patient age 16 year ) , assent child age 8 year wherever possible . Hypersensitivity active ingredient , gelatin gentamicin ( possible trace residue ) [ notwithstanding allergy egg protein ] Previous systemic allergic reaction LAIV Previous allergic reaction influenza vaccine ( LAIV ) relative contraindication , must discuss site PI confirm patient suitability Children/adolescents clinically immunodeficient due condition immunosuppressive therapy : acute chronic leukaemia ; lymphoma ; symptomatic HIV infection ; cellular immune deficiency ; highdose corticosteroids** . **Highdose steroid define treatment course least one month , equivalent dose prednisolone 20mg per day ( age ) ; child 20kg , dose 1mg/kg/day . Children adolescents young 18 year age receive salicylate therapy association Reye 's syndrome salicylates wildtype influenza infection . pregnancy Febrile â‰¥ 38.0 ' C last 72 hour Acute wheeze last 72 hour require treatment beyond normally prescribed regular use child 's treat healthcare professional Recent admission hospital last 2 week acute asthma Current oral steroid asthma exacerbation course complete within last 2 week Received blood blood product within past 12 week Any significant condition circumstance , opinion investigator , may either put participant risk participation study , may influence result study , participant 's ability participate study .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>